Why are Immuno-Oncology compounds different?
Why are Immuno-Oncology compounds different?
Immuno-Oncology: a concept or already a reality?
Clinicopathological spectrum of colorectal cancer in Africa
Chemoprevention and screening programmes for bladder cancer
Prevention of colorectal and lung cancer subtypes with aspirin
Peruvian efforts to produce a cancer registry
Diet, the microbiome, and colon cancer risk
Engineering of polymeric nanoparticles for medical applications
Developing trials with surgeons: Hughes Abdominal Repair Trial (HART) Trial
Traditional and personalised models of therapy in gastrointestinal and endocrine tumours: the role of histological and clinical markers
The revolution in personalised healthcare: Towards improved outcomes in oncology: Conclusion and Summary
European Cancer Congress 2013 - News Roundup